Florida Market Guide
Florida Kratom Testing: T191 and T814
Map Florida's current listed-compound framework to the analytical results, inputs, and calculated reporting you can request from Cora Science.
This maintained page separates Attorney General Emergency Rule 2ER26-1 from the repealed FDACS labeling rule and shows the current six-of-seven T191 coverage without treating T814 as another analytical method.
Current distinction. The official 2ER26-1 record remains effective from July 1, 2026 through its scheduled June 30, 2027 expiration. The separate 5KER26-9 concentration-and-ratio labeling rule was repealed effective August 6, 2026. Its label disclosures are not currently required under that repealed rule.
Current Framework
What 2ER26-1 addresses
The final adopted rule record names seven compounds. Its official emergency-rule summary describes product-form thresholds and a separate mitragynine mass relationship.
Solids and powders
Above 1 mg/g
The rule summary includes solid and powdered products, including encapsulated materials.
Liquids
Above 1 mg/mL
The rule summary includes liquid products such as beverages, extracts, and tinctures.
Mitragynine relationship
At least 100:1 by mass
The rule also addresses products with fewer than 100 parts mitragynine for every one part of the listed compounds, individually or combined.
Separate agency position. A July 2026 FDACS industry notice for the now-repealed labeling framework separately stated that FDACS considered 7-acetoxymitragynine, MGM-15, and MGM-16 adulterants under section 500.10, Florida Statutes. The August repeal explanation does not state that FDACS withdrew that separate position. Obtain current FDACS or legal guidance before relying on the earlier notice.
Exact Coverage
Seven compounds in the rule; six reported by current T191
T191 produces individual analytical results for the six marked as reported. A calculated package cannot fill a missing underlying analytical result.
- 01 7-hydroxymitragynine (7OH) Reported
- 02 9-hydroxycorynantheidine (9OH) Reported
- 03 10-hydroxycorynantheidine (10OH) Not reported
- 04 Mitragynine pseudoindoxyl (pseudo) Reported
- 05 7-acetoxymitragynine Reported
- 06 Dihydro-7-hydroxymitragynine (MGM-15) Reported
- 07 9-fluoro-7-hydroxymitragynine (MGM-16) Reported
Known coverage gap: 10-hydroxycorynantheidine (10OH). As last confirmed August 3, 2026, T191 does not report 10OH because a suitable reference material is not commercially available. T191 therefore does not measure all seven compounds named in 2ER26-1.
Three Distinct Roles
Measurements, inputs, and calculated reporting
Choose based on the output you need. T814 uses applicable analytical results; it does not independently retest the sample.
Analytical input
T102
Supplies applicable mitragynine concentration and per-unit results used by the T814 calculation and reporting package.
Analytical measurements
T191 — Florida Listed Compounds Panel
Reports individual results for six of the seven compounds currently listed in 2ER26-1, with result qualifiers and applicable method detection limits.
Calculated and organized output
T814 — Florida Calculation and Reporting Package
Combines applicable T102 and T191 results into conversions, totals, ratios, declaration-format values, and an organized reporting table. It is not a third analytical method.
Rule-To-Offering Matrix
What each part contributes
Current rule item means the Florida rule addresses that constituent, threshold, unit, or relationship. It does not mean Florida prescribes a particular Cora test or report format. Confirm marks configuration-specific facts that have not been approved for a universal public claim.
On a narrow screen, scroll the matrix horizontally to review every offering column.
| Analyte or reporting item | Florida rule or status | T102 | T191 | T814 |
|---|---|---|---|---|
| Mitragynine Analytical result and ratio input |
Current rule item
Provides the mitragynine side of the rule's mass relationship. |
Reported
Reports applicable mitragynine concentration and per-unit results. |
Not applicable
T191 supplies the listed-derivative results, not the T102 mitragynine input. |
Input
Uses the applicable T102 result; it does not remeasure mitragynine. |
| 7-hydroxymitragynine (7OH) Listed-compound result |
Current rule item
Named in 2ER26-1. |
Reported
Also appears in applicable Mitragyna profiles; confirm order mapping. |
Reported
Individual analytical result. |
Input
Uses and organizes the applicable T191 result. |
| 9-hydroxycorynantheidine (9OH) Listed-compound result |
Current rule item
Named in 2ER26-1. |
Not applicable
Not a T102 reporting input. |
Reported
Individual analytical result. |
Input
Uses and organizes the applicable T191 result. |
| 10-hydroxycorynantheidine (10OH) Listed-compound result |
Current rule item
Named in 2ER26-1. |
Not applicable
Not a T102 reporting input. |
Not reported
Not included as of August 3, 2026; a suitable reference material is not commercially available. |
Not reported
Cannot create an underlying 10OH analytical result that T191 does not report. |
| Mitragynine pseudoindoxyl Listed-compound result |
Current rule item
Named in 2ER26-1. |
Reported
Also appears in the expanded Mitragyna profile; confirm order mapping. |
Reported
Individual analytical result. |
Input
Uses and organizes the applicable T191 result. |
| 7-acetoxymitragynine Listed-compound result |
Current rule item
Named in 2ER26-1. |
Not applicable
Not a T102 reporting input. |
Reported
Individual analytical result. |
Input
Uses and organizes the applicable T191 result. |
| Dihydro-7-hydroxymitragynine (MGM-15) Listed-compound result |
Current rule item
Named in 2ER26-1. |
Not applicable
Not a T102 reporting input. |
Reported
Individual analytical result. |
Input
Uses and organizes the applicable T191 result. |
| 9-fluoro-7-hydroxymitragynine (MGM-16) Listed-compound result |
Current rule item
Named in 2ER26-1. |
Not applicable
Not a T102 reporting input. |
Reported
Individual analytical result. |
Input
Uses and organizes the applicable T191 result. |
| Product-form unit conversion Calculated value and report presentation |
Current rule item
The rule distinguishes mg/g solids from mg/mL liquids. |
Input
Supplies applicable mitragynine input. |
Input
Supplies applicable listed-compound inputs. |
Calculated
Organizes applicable mg/g or mg/mL conversions; liquid density may be needed. |
| Regulated Component Total Calculated value |
Current rule item
2ER26-1 addresses the listed compounds individually or combined; the rule does not prescribe Cora's report label. |
Not applicable
Not calculated by T102. |
Input
Supplies the reported constituent results. |
Calculated
Reports the controlled calculated total. |
| Mitragynine-to-regulated-component ratio Calculated value |
Current rule item
Represents the rule's 100-parts-mitragynine mass relationship. |
Input
Supplies the mitragynine result. |
Input
Supplies the listed-compound results. |
Calculated
Calculates and reports the controlled ratio. |
| Declaration-format values Report presentation |
Repealed
The separate 5KER26-9 concentration and ratio labeling rule is repealed. |
Not applicable
Not a T102 report package. |
Not applicable
Not part of T191's analytical result set. |
Optional
Declaration-format values remain available as optional reporting support. |
| PASS/FAIL presentation Decision rule and report presentation |
Not applicable
The rule does not prescribe a Cora Science certificate format. |
Not applicable
Not a T102 report package. |
Not applicable
T191 supplies analytical results. |
Optional
Can organize applicable determinations under controlled decision rules; it does not certify legal compliance. |
| Configuration-specific ordering details Matrix, sample, limits, units, density, timing, and price |
Not applicable
These are laboratory configuration details, not terms set by the rule record. |
Confirm
Confirm the applicable input during quote review. |
Confirm
Confirm matrix fit, sample quantity, reporting limits and units, and timing. |
Confirm
Confirm density needs, controlled calculations, report outputs, timing, and price. |
Ordering Path
Start with the output you need
The configured quote actions below prefill Florida and the relevant service request. Every form field remains editable for your actual product and objective.
Individual analytical results
Request T191
Use this path for the individual Florida-listed-compound results currently included in T191. Ordering reference: Test Code 191.
Configure a T191 QuoteCombined calculated reporting
Request T814 with applicable inputs
Use this path when you want applicable T102 and T191 results combined into the controlled calculation and reporting package. Ordering reference: Test Code 814.
Configure a T814 QuoteConfirm the configuration before submitting samples
Matrix eligibility, required sample quantity, reporting limits and units, result qualifiers, any liquid-density need, exact T814 calculations and decision rules, current turnaround, and price are confirmed during quote review. Share the product form, target market, requested output, and deadline.
Historical T813 note: the former 400 ppm dry-weight package is not a standard catalog option after August 6, 2026. It may be available only by custom request after advance technical review.
Primary Sources
Official records used for this review
These direct government records control over this page's summary. Open them before making a time-sensitive regulatory decision.
- Florida Emergency Rule 2ER26-1 — official rule record Current rule record, effective July 1, 2026, with scheduled expiration June 30, 2027.
- 2ER26-1 — final adopted version Final Florida Administrative Code notice naming the seven compounds and effective dates.
- 2ER26-1 — emergency-rule summary Official summary of product-form thresholds and the mitragynine mass relationship.
- 5KER26-9 — final repeal record Final record showing repeal of the separate labeling rule effective August 6, 2026.
- 5KER26-9 — FDACS repeal explanation FDACS explanation for waiting on labeling requirements while conditions change.
- FDACS July 2026 industry notice Historical agency notice for the now-repealed labeling framework and a separate adulteration position; use with the repeal records and current agency or legal guidance.
Maintenance
Reviewed August 8, 2026
Content owner: Cora Science technical and regulatory review.
Immediate review trigger: Review immediately if Florida or federal authorities change the rule record or related guidance; if the T102, T191, T814, or T813 service definitions, calculations, decision rules, or report templates change; or if 10-hydroxycorynantheidine reference-material availability changes.
Customer responsibility. This guide is informational and is not legal advice. Requirements, agency interpretations, and federal actions may change. Cora Science reports analytical and calculated outputs within the agreed scope; it does not approve a product, determine every legal obligation, or certify legal compliance. The customer is responsible for confirming current requirements and product eligibility with appropriate regulatory or legal advisors.